tyrosine and Chondrodysplasia Punctata

tyrosine has been researched along with Chondrodysplasia Punctata in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Couloigner, V; Elmaleh-Bergès, M; Legeai-Mallet, L; Messaddeq, N; Munnich, A; Pannier, S; Romand, R	1

Other Studies

1 other study(ies) available for tyrosine and Chondrodysplasia Punctata

Article	Year
Activating Fgfr3 Y367C mutation causes hearing loss and inner ear defect in a mouse model of chondrodysplasia. Biochimica et biophysica acta, 2009, Volume: 1792, Issue:2 Topics: Animals; Chondrodysplasia Punctata; Disease Models, Animal; Enzyme Activation; Hearing Loss; Heterozygote; Labyrinth Diseases; Mice; Mice, Transgenic; Microscopy, Electron, Transmission; Mutation; Receptor, Fibroblast Growth Factor, Type 3; Tyrosine	2009

Article

Year

Activating Fgfr3 Y367C mutation causes hearing loss and inner ear defect in a mouse model of chondrodysplasia.

Biochimica et biophysica acta, 2009, Volume: 1792, Issue:2

Topics: Animals; Chondrodysplasia Punctata; Disease Models, Animal; Enzyme Activation; Hearing Loss; Heterozygote; Labyrinth Diseases; Mice; Mice, Transgenic; Microscopy, Electron, Transmission; Mutation; Receptor, Fibroblast Growth Factor, Type 3; Tyrosine

2009